Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy. Boardman AP, Gutgarts V, Flynn J, Devlin SM, et al. Haematologica 2025;110:651-664.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boardman AP, Gutgarts V, Flynn J, Devlin SM, et al. Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy. Haematologica 2025;110:651-664.
PMID: 39568416